<DOC>
	<DOCNO>NCT03050216</DOCNO>
	<brief_summary>This multi-institutional Simon 's optimal two-stage phase II trial CD3/CD19 deplete , ALT-803 activate , haploidentical donor NK cell subcutaneous ALT-803 give lymphodepleting chemotherapy ( CY/FLU ) treatment refractory release acute myelogenous leukemia ( AML ) .</brief_summary>
	<brief_title>QUILT-3.033 : Haplo NK With SQ ALT-803 Adults With Relapsed Refractory AML</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Inclusion Criteria ( ( Recipient ) : Meets ONE follow disease criterion : 1 . Primary AML induction failure : CR 2 induction attempt 2 . Relapsed AML Secondary AML ( MDS treatment relate ) : CR 1 cycle standard reinduction therapy 3 . AML relapse &gt; 1 year transplant : No reinduction require , 1 reinduction cycle allow . 4 . Relapsed AML patient &gt; 60 year age 1 cycle standard chemotherapy require . 5 . Available related HLAhaploidentical donor ( age 12 75 year ) least Class I serologic type A &amp; B locus 6 . Karnofsky Performance Status ≥ 60 % 7 . Patients must adequate organ within 14 day ( 28 day pulmonary cardiac ) define : Creatinine : ≤ 2.0 mg/dL Hepatic : AST ALT &lt; 3 x upper limit institutional normal Pulmonary Function : oxygen saturation ≥ 90 % room air ; PFT 's require symptomatic prior know impairment must pulmonary function &gt; 50 % correct DLCO FEV1 . Cardiac Function : LVEF ≥ 40 % echocardiography MUGA , uncontrolled angina , severe uncontrolled ventricular arrhythmia , electrocardiographic evidence acute ischemia active conduction system abnormality . . 8 . Able prednisone immunosuppressive medication least 3 day prior NK cell infusion ( exclude preparative regimen premedications ) . 9 . Agrees use contraception therapy 4 month completion therapy . 10 . Voluntary write consent prior performance research relate procedure Exclusion Criteria ( Recipient ) : 1 . Acute leukemias ambiguous lineage 2 . Pregnant breastfeed The agent use study include fall Pregnancy Category D know teratogenic potential . Women child bear potential must negative pregnancy test screening . 3 . Active autoimmune disease require immunosuppressive therapy . 4 . History severe asthma currently chronic medication ( mild asthma require inhaled steroid eligible ) . 5 . New progressive pulmonary infiltrates screen chest xray chest CT scan unless clear study Pulmonary . Infiltrates attribute infection must stable/improving ( associated clinical improvement ) 1 week appropriate therapy ( 4 week presume documented fungal infection ) . 6 . Uncontrolled bacterial , fungal viral infection include HIV1/2 active hepatitis C/B chronic asymptomatic viral hepatitis allow . 7 . Received investigational agent within 14 day start study treatment ( 1st dose fludarabine ) Criteria For Initial Donor Selection : 1 . HLAhaploidentical related donor ( age 12 75 year ) donor/recipient match base minimum intermediate resolution DNA base Class I type A B locus It recognize individual institution may differ donor age guideline . This acceptable long donor young 12 year old 75 year . 2 . At least 40 kilogram body weight . 3 . In general good health determine evaluate medical provider . 4 . Adequate organ function define : Hematologic : hemoglobin , WBC , platelet within 10 % upper low limit normal range test ( gender base hemoglobin ) Hepatic : ALT &lt; 2 x upper limit normal , Renal : serum creatinine &lt; 1.8 mg/dl 5 . Performance donor infectious disease screen panel include CMV Antibody , Hepatitis B Surface Antigen , Hepatitis B Core Antibody , Hepatitis C Antibody , HIV 1/2 Antibody , HTLVA 1/2 Antibody , Rapid Plasma Reagin Trypanosoma Cruzi ( T. Cruzi ) per current standard institutional donor screen must negative HIV active hepatitis B . 6 . Not pregnant female childbearing potential must negative pregnancy test within 7 day apheresis . 7 . Voluntary write consent ( assent donor &lt; 18 year age ) prior performance research related procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>